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a b s t r a c t
Wnt proteins regulate cell behavior via a canonical signaling pathway that induces β-catenin dependent
transcription. It is now appreciated that Wnt/β-catenin signaling promotes the expansion of the second
heart ﬁeld (SHF) progenitor cells that ultimately give-rise to the majority of cardiomyocytes. However,
activating β-catenin can also cause the loss of SHF progenitors, highlighting the necessity of precise
control over β-catenin signaling during heart development. We recently reported that two non-
canonical Wnt ligands, Wnt5a and Wnt11, act cooperatively to attenuate canonical Wnt signaling that
would otherwise disrupt the SHF. While these data reveal the essential role of this anti-canonical Wnt5a/
Wnt11 signaling in SHF development, the mechanisms by which these ligands inhibit the canonical Wnt
pathway are unclear. Wnt11 was previously shown to inhibit β-catenin and promote cardiomyocyte
maturation by activating a novel apoptosis-independent function of Caspases. Consistent with these
data, we now show that Wnt5a and Wnt11 are capable of inducing Caspase activity in differentiating
embryonic stem (ES) cells and that hearts fromWnt5a/; Wnt11/ embryos have diminished Caspase
3 (Casp3) activity. Furthermore, SHF markers are reduced in Casp3 mutant ES cells while the treatment
of wild type ES cells with Caspase inhibitors blocked the ability of Wnt5a and Wnt11 to promote SHF
gene expression. This ﬁnding was in agreement with our in vivo studies in which injecting pregnant mice
with Caspase inhibitors reduced SHF marker expression in their gestating embryos. Caspase inhibition
also blocked other Wnt5a/Wnt11 induced effects, including the suppression of β-catenin protein
expression and activity. Interestingly, Wnt5a/Wnt11 treatment of differentiating ES cells reduced both
phosphorylated and total Akt through a Caspase-dependent mechanism and phosphorylated Akt levels
were increased in the hearts Caspase inhibitor treated. Surprisingly, inhibition of either Akt or PI3K in ES
cells was an equally effective means of increasing SHF markers compared to treatment with Wnt5a/
Wnt11. Moreover, Akt inhibition restored SHF gene expression in Casp3 mutant ES cells. Taken together,
these ﬁndings suggest that Wnt5a/Wnt11 inhibit β-catenin to promote SHF development through
Caspase-dependent Akt degradation.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Congenital heart disease (CHD) affects nearly 1% of live births
and is the most common class of birth defect (Tennstedt et al.,
1999). The intercellular signals that coordinate heart development
and how defects in these cues cause CHD have therefore become
areas of intense interest within developmental biology since a
better understanding of these processes may aid the discovery of
new methods to detect and treat CHD. Cardiac muscle is derived
from two groups of progenitor cells initially located within a
region of mesoderm underlying the head folds of early embryos
called the cardiac crescent (Buckingham et al., 2005; Cai et al.,
2003; Kelly et al., 2001; Kelly and Buckingham, 2002; Marguerie
et al., 2006; Zaffran et al., 2004). First heart ﬁeld (FHF) cardiac
progenitor cells occupy the lateral region of the cardiac crescent,
which will come into contact at the ventral midline as the body
wall closes (Buckingham et al., 2005; Zaffran et al., 2004). Once at
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the midline, FHF progenitors form a tube and differentiate rapidly
to form the linear heart of the early embryo, which will later give
rise to the left ventricle (Buckingham et al., 2005; Zaffran et al.,
2004). Second heart ﬁeld (SHF) cardiac progenitors, which are
identiﬁed by their expression of the lim/homeobox transcription
factor Islet1 (Isl1), occupy more medial areas within cardiac
crescent that become the mesothelium dorsal to the heart tube
called the dorsal mesocardium (DM) (Cai et al., 2003; Verzi et al.,
2005). In contrast to FHF progenitors, SHF progenitors remain
undifferentiated and expand within the pharyngeal mesenchyme
and DM before migrating to the poles of heart tube to become the
majority of cardiomyocytes in the remaining chambers (Cai et al.,
2003; Verzi et al., 2005).
In addition to the FHF and SHF, the cardiac neural crest (CNC) plays
an essential role in cardiac development. CNC cells are initially located
in the dorsal neural tube but delaminate and migrate ventrally into
the heart, where they form the initial septum between the aorta and
pulmonary trunk and contribute smooth muscle to the proximal
outﬂow tract and ascending aorta (Snider et al., 2007). CNC cells also
invade the semilunar cushion and are essential for outﬂow tract (OFT)
valve development even though their descendants are not maintained
in the adult structures (Snider et al., 2007). SHF progenitor and CNC
cells lie in close proximity to one another and communication bet-
ween the two cell types is essential for the proper development of
both pools of progenitors (Rentschler et al., 2010; Rochais et al., 2009;
Snarr et al., 2008; Snider et al., 2007; Vincent and Buckingham, 2010).
Perturbations of the SHF and CNC therefore cause a similar spectrum
of OFT defects, including persistent truncus arteriosis, double outlet
right ventricle, tetralogy of Fallot and ventricular septal defects
(Gittenberger-de Groot et al., 2013; Keyte and Hutson, 2012; Snider
et al., 2007). Moreover, recent intersectional fate-mapping experi-
ments have identiﬁed a lineage of cells that expresses both Wnt1 and
Isl1 at some time in their history (Engleka et al., 2012). Since Wnt1 is
only expressed in CNC cells within the neural tube and repressed
shortly after these cells delaminate and begin their migration toward
the heart (Danielian et al., 1997), these data have been interpreted to
mean that a subset of CNC cells express Isl1, though it is also possible
that there is transient Wnt1 expression in some SHF progenitors that
has yet to be detected.
Wnt proteins are secreted ligands that signal through multiple
pathways to regulate critical cellular behaviors, including the deter-
mination of cell fates, the rates of cellular proliferation, survival and
differentiation as well as the levels cellular motility and adhesion
(Cadigan and Nusse, 1997; Niehrs and Acebron, 2012; Teo and Kahn,
2010). Effects of Wnt proteins on gene expression are most often
mediated by a canonical Wnt signaling pathway that inactivates two
constitutively active kinases, Glycogen synthase kinase 3α and Glyco-
gen synthase kinase 3β (Gsk3α⧸β), that act in a complex with other
proteins to target the unbound form of β-catenin, a cell-cell adhesion
protein, for degradation (Doble and Woodgett, 2003; Wu and Pan,
2010). Therefore, in the presence of Wnt signaling, β-catenin accu-
mulates to high levels within the cytoplasm and nucleus, where it
complexes with TCF/Lef1 family transcription factors to induce target
gene transcription (Angers and Moon, 2009; Eastman and Grosschedl,
1999). In addition to signaling through β-catenin, Wnt proteins can
activate non-canonical effectors such as Rho-family small GTPases,
Mitogen activated protein kinases (MAPK) and Protein kinase C (PKC)
(Kuhl, 2002; Strutt, 2003; Tada et al., 2002). This non-canonical Wnt
signaling regulates the cytoskeleton to control cellular polarity,
motility and adhesion. Additionally, non-canonical Wnt signaling
frequently inhibits the canonical Wnt pathway and is believed to
restrict the levels and duration of canonical Wnt signaling in several
contexts (Mikels and Nusse, 2006; Topol et al., 2003; Westfall et al.,
2003).
The balance between canonical and non-canonical Wnt signal-
ing is essential for the growth and differentiation of SHF cardiac
progenitor cells. We as well as others have found that loss of
β-catenin in both the FHF and SHF reduces the numbers of SHF
progenitor cells and disrupts SHF-derived structures without
affecting the FHF, suggesting that the SHF is uniquely dependent
on β-catenin dependent transcription (Ai et al., 2007; Cohen et al.,
2008, 2007; Klaus et al., 2007; Kwon et al., 2007; Lin et al., 2007).
In contrast, expressing a cre-inducible constitutively active form of
β-catenin can either increase or decrease the numbers of SHF
progenitor cells depending on the cre-line used to induce its
expression (Cohen et al., 2007; Kwon et al., 2007, 2009; Qyang
et al., 2007). Consistent with these later data, two non-canonical
Wnt proteins expressed at the anterior pole to the heart tube
during SHF migration, Wnt5a and Wnt11, promote cardiogenesis
in the normally non-cardiogenic posterior mesoderm of early
embryos as well as differentiating stem cells by inhibiting cano-
nical Wnt signaling (Eisenberg and Eisenberg, 1999; Koyanagi
et al., 2005, 2009; Pandur et al., 2002; Schneider and Mercola,
2001; Terami et al., 2004). Yet while these data suggest that Wnt5a
and Wnt11 act in early cardiac progenitors, Wnt5a and Wnt11
mutations cause mild heart defects due to problems in cell–cell
adhesion and cytoskeleton organization in differentiating cardio-
myocytes (Nagy et al., 2010; Schleiffarth et al., 2007; Zhou et al.,
2007). However, we have more recently shown that mice lacking
both Wnt5a and Wnt11 die early in embryogenesis with single
chambered hearts resembling those caused by SHF ablation
(Cohen et al., 2012). Further analysis revealed a loss of SHF
progenitor cells and an associated increase in canonical Wnt
signaling within the OFT and adjacent mesenchyme of Wnt5a /;
Wnt11/ embryos relative to controls. Treating embryoid bodies
(EBs) with Wnt5a and Wnt11 also caused a synergistic increase in
cardiac progenitor gene expression, an effect that is blocked by
forced β-catenin activation and mimicked by canonical Wnt path-
way inhibition. Together, these data indicate that Wnt5a and Wnt11
act cooperatively to restrain canonical Wnt signaling in the SHF that
would otherwise disrupt cardiac progenitor development.
The effects of Wnt5a and Wnt11 on SHF progenitors may be
mediated by the Caspase-dependent inhibition of the canonical Wnt
pathway. Wnt11 overexpression has been shown to promote later
events of cardiomyocyte differentiation, such as the expression of
cardiac Troponin T and the appearance of sarcomeres, in cultures of
differentiating P19 embryonic carcinoma cells by inhibiting the
canonical Wnt pathway (Abdul-Ghani et al., 2011). Interestingly, these
effects of Wnt11 were associated with an increase in the activity of
Caspases, a large family of cysteine proteases that play critical roles in
programmed cell death (Elmore, 2007; McIlwain et al., 2013), and can
be blocked by the addition of Caspase inhibitors to the culture media
(Abdul-Ghani et al., 2011). Importantly, the increase in Caspase activity
observed with Wnt11 was not associated with an increase in the
numbers of cells marked by TUNEL staining (Abdul-Ghani et al., 2011),
suggesting it is unrelated to apoptosis. Caspases have also been shown
to have apoptotic-independent roles in the differentiation of skeletal
muscle (Fernando et al., 2002; Murray et al., 2008). All in all, these
data suggest that Wnt11 promotes cardiomyocyte maturation via the
Caspase-dependent inhibition of the canonical Wnt pathway. While
the aforementioned study focused on later cardiac development, these
data raised the possibility that the cooperative effects of Wnt5a and
Wnt11 on the early development of cardiac progenitor cells are
similarly mediated by non-apoptotic Caspase signaling.
The data presented in this manuscript suggest that cooperative
Wnt5a/Wnt11 signaling inhibits the canonical Wnt pathway and
promotes SHF development via the Caspase-dependent inhibition
of Akt. Treatment of mouse ES cells derived EBs with recombinant
Wnt5a and Wnt11 increased the processing of Casp3, Caspase 6
(Casp6) and Caspase 7 (Casp7) into their active forms, which
correlated with increased function as evidenced by the activation
of a luciferase based Casp3/7 reporter. Conversely, staining for
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cleaved-Casp3 was reduced in the OFT and surrounding mesench-
yme of Wnt5a /; Wnt11 / embryos relative to controls.
Furthermore, SHF markers are reduced in Casp3 mutant ES cells
while the treatment of wild type ES cells with Z-VAD-FMK, a broad
spectrum Caspase inhibitor, blocked the ability of Wnt5a and
Wnt11 to promote SHF gene expression. Consistent with these
data, SHF marker expression was reduced in the embryos of
pregnant mice injected with Z-VAD-FMK relative to controls.
Caspase inhibition also prevented the reduction of β-catenin
proteins and activity associated with Wnt5a/Wnt11 treatment.
Interestingly, staining for phosphorylated Akt was increased in the
hearts of Z-VAD-FMK treated embryos relative to wild type
controls. Wnt5a/Wnt11 treatment also caused the Caspase-
dependent loss of both phosphorylated and total Akt protein in
differentiating ES cells while inhibiting either Akt or its upstream
activator PI3K increased SHF marker expression to levels similar to
those observed following Wnt5a/Wnt11 treatment. Finally, treat-
ing EBs made from Casp3/ ES cells with an Akt inhibitor
restored SHF gene expression to levels similar to those in control
EBs. Taken together, these data suggest a model in which coop-
erative Wnt5a/Wnt11 signaling inhibits β-catenin and promotes
SHF development by inducing the Caspase-dependent reduction
of Akt activity.
Materials and methods
Generation of Wnt5a /; Wnt11 / embryos and in utero inhibition
of Caspase function
Mice carrying previously published alleles of Wnt5a and Wnt11
were interbred to produce Wnt5a/; Wnt11 / and wild type
embryos as previously described (Cohen et al., 2012). Genotyping for
Wnt5a and Wnt11 was performed as described (Majumdar et al.,
2003; Yamaguchi et al., 1999). For the in utero inhibition of Caspase
function, male and female CD1 mice were obtained from Charles River
and mated. The presence of copulation plugs was used to identify
pregnant females on day 0.5 of gestation (E0.5). Pregnant females
were given intra-peritoneal injections of 5 ml/g body weight of either
1 mM Z-VAD-FMK (Calbiochem, 627610), a synthetic peptide that
inhibits a broad range of Caspase family members (Garcia-Calvo et al.,
1998; Slee et al., 1996), 1 mM Ac-DEVD-CHO (Calbiochem, 235420), a
potent and more selective inhibitor of Casp3 (Garcia-Calvo et al., 1998;
Nicholson et al., 1995), or their vehicle DMSO on E6.5, E7.5 and E8.5 of
pregnancy. Injected females were then sacriﬁced on E9.5 and their
gestating embryos harvested for subsequent analysis. The University
Committee on Animal Resources (UCAR) at the University of Rochester
approved all protocols and procedures.
Histology and immunological staining
Wnt5a /; Wnt11/ embryos and their wild type siblings as
well as embryos from pregnant females injected with Z-VAD-FMK
and DMSO were collected at E9.5 and ﬁxed in 4% PFA before being
dehydrated with a series of washes in increasing ethanol concen-
tration, embedded in parafﬁn and sectioned as described (Cohen
et al., 2012, 2007; Nagy, 2003). Immunohistochemical and immu-
noﬂuorescent staining with primary antibodies speciﬁc for Isl1
(Millipore, AB4326), PlexinA2 (Santa Cruz, sc-10144), Nkx2.5
(Santa Cruz, sc-8697), cleaved-Casp3 (Cell Signaling, 9664),
phospho-ser473-Akt (Cell Signaling, 4060) and active-β-catenin
(Millipore, 05-665) as well as biotinylated secondary antibodies
recognizing mouse, rabbit and goat IgG (Vector Laboratories,
BA-9200, BA-1000 and BA-9500, respectively), Alexa Fluor 488
conjugated anti-goat IgG (Jackson Immunoresearch, 705-545-147)
or Dylight 594 conjugated anti-rabbit IgG (Vector Laboratories,
DI-1094) was performed as described (Cohen et al., 2012, 2007;
Nagy, 2003). Biotinylated secondary antibodies were detected
using the Vectastain Elite ABC and DAB Peroxidase Substrate kits
(Vector Laboratories, PK-1000 and SK-4100, respectively) accord-
ing to the manufacturer’s protocol. TUNEL staining was performed
using the ApopTags Red kit (Millipore, S7165) according to the
manufacturer’s protocol.
Generation and culture of EBs
The TL1 line mouse ES cells was generated by Dr. Patricia A
Labosky and had previously been used to model the effects of Wnt5a
and Wnt11 on cardiac progenitor development in vitro (Cohen et al.,
2012). The Casp3/ , Casp3 /þ , rev-Casp3-CA and rev-Casp3-mut
mouse ES cell lines were previously used to examine the roles of
Casp3 in the switch from self-renewal to differentiation described
(Fujita et al., 2008). All lines of mouse ES cells were grown on
inactivated mouse embryonic ﬁbroblasts (Millipore, PMEF-N) in high
glucose DMEM (Life Technologies, 11965-092) supplemented with 15%
FBS (Hyclone, SH309100HI), antibiotic-antimycotic (Life Technologies,
15240-062), Glutamaxs (Life Technologies, 35050-061), non-essential
amino acids (Life Technologies, 11140-050), sodium pyruvate (Life
Technologies, 11360070), β-mercaptoethanol (Fisher Scientiﬁc,
O3446I-100) and LIF (Millipore, ESG1107) as described (Cohen et al.,
2012). To initiate differentiation, cells were dissociated, suspended at
5104 cells/ml in differentiation media (same as growth media but
with 20% FBS and without LIF) and used to make 20 ml drops on the
underside of petri-dish lids (Cohen et al., 2012; Fuegemann et al.,
2010). Cells were then cultured as hanging drops for 48 h to form EBs,
which were then cultured for another 2 days in poly-HEMA (Sigma-
Aldrich, P3932) coated dishes.
On day 4 of differentiation, EBs were transferred to gelatin
(Sigma-Aldrich, G1393) coated dishes containing control media,
media containing 200 ng/ml recombinant Wnt5a (RnD Systems,
645-WN-10), 200 ng/ml Wnt11 (RnD Systems, 6179-WN-10) or
100 ng/ml Wnt5a and 100 ng/ml Wnt11. When indicated, 10 mM
Z-VAD-FMK, 1 mM Akt-i-VIII (Calbiochem, 124018), 1 mM PI-103
(Calbiochem, 528100), 50 nm Bio (Calbiochem, 361550), 50 nM
meBio (Cabiochem, 361556), 100 nM XAV939 (Selleck Chemicals,
S1180) or DMSO was added to the culture media. EBs were then
either cultured for 48 h and lysed in Trizol (Life Technologies,
15596-026) for total RNA extraction or cultured for 24 h and lysed
in RIPA buffer supplemented with a mix of protease and phos-
phatase inhibitors (Thermo Scientiﬁc, PI-89901 and PI-78420,
respectively) for Western blotting. To determine if blocking Akt
function was sufﬁcient to restore Isl1 expression in Casp3 / ES
cells, EBs made from Casp3 / and Casp3/þ ES cells were treated
with either 1 mM Akt-Inhibitor VIII or DMSO between days 3
and 5 of differentiation before being lysed in Trizol RNA isolation.
To determine if Caspase overexpression was sufﬁcient to mimic
the effects of Wnt5a and Wnt11 on Isl1 expression, EBs made from
rev-Casp3-ca and rev-Casp3-mut ES cells were treated with
1 mg/ml doxycycline from days 4 to 5 of differentiation to induce
Casp3 expression as described (Fujita et al., 2008).
Measuring Caspase and TCF activity in EBs
To measure the effects of Wnt5a and Wnt11 on the activities of
Casp3 and Casp7, EBs were made from TL1 ES cells and transferred to
gelatin-coated dishes containing either control media or media
supplemented with recombinant Wnt5a and Wnt11 proteins on day
4 of differentiation. EBs were then cultured for 24 h before being lysed
in a hypotonic extraction buffer as described (Botto et al., 2011).
Protein concentrations were determined using the DC Protein Assay
System (Bio-Rad, 500-0111) according to manufacturer’s protocol,
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allowing each sample to be adjusted to a ﬁnal concentration of
1 mg/ml. 5 mL aliquots of lysate from each sample were then placed
into thewells of an opaquewhite 96-well assay plate containing 50 ml
of the Caspase-Glo 3/7 Assay reagent (Promega, G8090) and incubated
for 30 min. The luminescence of each well was then determined using
a Biotek Synergy HT Microplate Reader. Reported values are the
mean7the standard deviation for measurements taken from at least
three independent replicates. Po0.05 by two-tailed Student’s t-test
indicated statistical signiﬁcance.
To measure the effects of Wnt5a and Wnt11 on β-catenin-
dependent transcription, TL1 mouse ES cells were transiently
transfected with Super 8x TOPFlash (Addgene, 12456), a reporter
which uses 8 tandem repeats of the consensus TCF/LEF binding
site to drive ﬁreﬂy luciferase expression in response to β-catenin
signaling, as well as the constitutively active Renilla luciferase
vector pRL-TK (Promega, E2241) using Effectene reagent (Qiagen,
301425) as described (Ko et al., 2009). Transfected ES cells were
used to generate EBs, which were then treated with Wnt5a, Wnt11
or Wnt5a and Wnt11 on day 4 of differentiation as described. After
24 h, luciferase activity was assayed using the Dual Luciferase
Assay System (Promega, E1910). Renilla luciferase values were
used to normalize for transfection efﬁciency. Reported values are
the mean7standard deviation. Po0.05 by two-tailed Student’s
t-test indicated statistical signiﬁcance.
Quantitative PCR (Q-PCR) and Western blotting
To examine the effects of Wnt5a and Wnt11 on transcription,
relative gene expression was calculated by the ΔCT method using
Gapdh as an endogenous control. For Q-PCR analysis of embryonic
hearts, graphs represent the average results from three indepen-
dent pools of RNA isolated from the heart-containing regions,
deﬁned as the heart and mesenchyme ventral to the foregut from
the second pharyngeal arch to the septum transversum, of at least
ﬁve embryos. For Q-PCR analysis of EBs, graphs represent the
average values from four pools of RNA isolated from independent
experiments. RNA was reverse transcribed using iScript Reverse
Transcription Supermix (Bio-Rad, 170-8840) and Q-PCR performed
on a Bio-Rad CFX386 thermocycler with SsoAdvanced Universal
SYBR Green Supermix (Bio-Rad, 172-5270). The primer pairs used
to detect Isl1, Nkx2.5, Tnni3 and Gapdh were previously described
(Cohen et al., 2012). The primers used to detect Akt1, Casp3, Casp6,
Casp7, PlexinA2 and p75 are listed in Supplementary Table 1. The
ΔCT values of all samples were normalized to the average ΔCT of
control samples, thus allowing the standard deviation to be
calculated from the ΔCT values of controls. Error bars represent
s.d. Student’s t-test with Po0.05 indicated statistical signiﬁcance.
To examine the effects of Wnt5a and Wnt11 on protein levels,
EBs were treated with Wnt5a and Wnt11 for 24 h as described and
lysed in RIPA buffer. Lysates were subjected to SDS-PAGE and
transferred to PVDF membranes, which were then subject to
Western blotting with antibodies recognizing cleaved forms of
Casp3, Casp6 and Casp7 (Cell signaling, 9664, 9761 and 9491,
respectively), total Casp3, Casp6 and Casp7 (Cell Signaling, 9662,
9762 and 9492, respectively), phospho-ser473-Akt, pan-Akt, Akt1
and Akt2 (Cell Signaling, 4060, 4691, 2938 and 3063, respectively),
activated (hypo-phosphorylated) β-catenin (Millipore, 05–665),
total β-catenin (BD Transduction Laboratories, 610154), β-Tubulin
(Cell Signaling, 2128) and Gapdh (Thermo Scientiﬁc, PA1987) as
well as HRP conjugated anti-mouse and anti-rabbit secondary
antibodies (Vector Laboratories, PI-2000 and PI-1000, respec-
tively). Signal was detected using Super Signal West Pico and
Super Signal West Femto ECL substrates (Thermo Scientiﬁc, PI-
34078 and PI-34094, respectively) and either Hyperﬁlm ECL (GE
Healthcare Biosciences, 28-9068-39) or a Bio-Rad Chemidoc XRS
imaging system.
Results
Cooperative Wnt5a/Wnt11 signaling induces executioner Caspase
activity in vivo and in vitro
Wnt11 was shown to promote the maturation of P19 cell derived
cardiomyocytes via Caspase-dependent β-catenin inhibition (Abdul-
Ghani et al., 2011). We therefore sought to determine if the loss of SHF
progenitors and increased canonical Wnt signaling observed in
Wnt5a/; Wnt11 / embryos was associated with altered Caspase
activity (Cohen et al., 2012). Caspases are separated into two classes
based on their roles in apoptotic signaling (Elmore, 2007; McIlwain
et al., 2013). Initiator Caspases are activated by extrinsic stimuli such as
death receptor signaling or intrinsic stimuli such as the release of
Cytochrome C from mitochondria. Once activated, initiator Caspases
will cleave the zymogen forms of the downstream executioner
Caspases, Casp3, Casp6 and Casp7, into their active forms, which then
act upon numerous targets. Among executioner Caspases, Wnt11 was
shown to speciﬁcally activate Casp3 in P19 cells (Abdul-Ghani et al.,
2011). Sections of E9.5 Wnt5a /; Wnt11 / embryos and their wild
type littermates were therefore stained with an antibody against
Casp3 cleaved at asparagine 175 (cleaved-Casp3). In wild type
embryos, cleaved-Casp3 was prominent in the walls of the OFT
(arrows in Fig. 1A) and DM (arrowheads in Fig. 1A), regions containing
SHF progenitors, as well as the roof of the OFT (dashed bracket in
Fig. 1A) and foregut endoderm. On the other hand, cleaved-Casp3 was
strongly reduced in these regions of Wnt5a /; Wnt11/ embryos
(arrows, arrowheads and dashed brackets in Fig. 1C). There were
slightly higher levels of residual cleaved-Casp3 staining in the OFT
walls than in the roof of the OFT and DM in Wnt5a/; Wnt11 /
embryos, suggesting that there may be redundant mechanisms
regulating Casp3 activity in these areas. Importantly, TUNEL staining
did not overlap with cleaved-Casp3 stained areas in the walls of the
OFT or DM in either wild type or Wnt5a/; Wnt11 / embryos
(arrows, arrowheads and dashed brackets in Fig. 1B and D). In contrast,
large numbers of cells located within the otic placode (arrows in
Fig. 1E and F) and neural tube (arrowheads in Fig. 1E and F) of
Wnt5a/; Wnt11/ embryos stained strongly for both cleaved
Casp3 and TUNEL. Moreover, while there were more TUNEL positive
cells in the pharyngeal mesenchyme of Wnt5a/; Wnt11/ than of
control embryos, the increase in apoptotic nuclei correlated with
decreased levels of cleaved-Casp3 staining. Taken together, these data
suggest that cleaved-Casp3 in the SHF is dependent on Wnt5a and
Wnt11 signaling and distinct from the Casp3 activation associated
with programmed cell death.
The loss of cleaved-Casp3 staining in the roof of the OFT was
interesting since this area contains high numbers of CNC cells
(Bradshaw et al., 2009), suggesting that the combined loss of
Wnt5a and Wnt11 may also disrupt the CNC. To address this issue,
sections of Wnt5a/; Wnt11/ and control embryos were
ﬂuorescently co-stained for Isl1 and PlexinA2, a Semaphorin
receptor expressed in migrating neural crest (Brown et al., 2001).
In wild type embryos, Is1 positive cells were present in the
anterior (arrowhead in supplemental Fig. 1A and C) as well as
posterior walls of the OFT and DM (large arrows in supplemental
Fig. 1A and C). Cells expressing lower levels of Isl1 were also
present in the roof of the OFT (small arrows in supplemental
Fig. 1A and C), which is contiguous with the foregut endoderm, as
well as in cells located within the lumen of the OFT (double-
headed arrows in supplemental Fig. 1A and C). While the Isl1
positive cells in the anterior wall of the OFT did not express
PlexinA2 (arrowhead in supplemental Fig. 1B and C), PlexinA2 was
expressed by the Isl1 positive cells in the posterior wall of the OFT
and DM (large arrows in supplemental Fig. 1B and C). Furthermore,
some of the cells expressing low levels of Isl1 in the roof and
lumen of the OFT (small arrows in supplemental Fig. 1B and C) and
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OFT lumen (double-headed arrows in supplemental Fig. 1B and C)
also expressed PlexinA2. In contrast, the expression of both Isl1 and
PlexinA2 were reduced or absent in the anterior (arrowheads in
supplemental Fig. 1D–F) and posterior wall of the OFT and DM
(large arrows in supplemental Fig. 1D–F) in the hearts of Wnt5a/;
Wnt11/ embryos relative to controls. While the lower level
expression of Isl1 and PlexinA2 in the lumen of the OFT (double-
headed arrows in supplemental Fig. 1D–F) was also absent in
Wnt5a /; Wnt11/ embryos, some cells in the roof of the OFT
(small arrows in supplemental Fig. 1D and E) continued to express
Isl1 but not PlexinA2. Together, these data suggest that both SHF
progenitor and CNC cells, including those that express Isl1, are
affected by the combined loss of Wnt5a and Wnt11 function.
Although Wnt11 was solely sufﬁcient to inhibit canonical Wnt
signaling and induce cardiac maturation in P19 cells (Abdul-Ghani
et al., 2011), the adenoviral vector used in these studies may have
produced Wnt11 at high enough concentrations to circumvent the
need for Wnt5a. To determine if the cooperative effects of Wnt5a and
Wnt11 on cardiac progenitor cells correlated with altered Caspase
activity, EBs were generated from TL1 mouse ES cells as previously
described (Cohen et al., 2012). On day four of differentiation, EBs were
plated on gelatin-coated dishes in the presence of Wnt5a, Wnt11 or
both. After 48 h, the levels of mRNA for Isl1, the pan-cardiac progenitor
marker Nkx2.5 and the executioner Caspases, Casp3, Casp6 and Casp7,
were analyzed by Q-PCR (Fig. 2A). Consistent with our previous
ﬁndings, Isl1 and Nkx2.5 levels were modestly increased in Wnt5a
treated EBs, moderately increased in Wnt11 treated EBs and strongly
increased in EBs treated with both Wnt5a and Wnt11. In contrast, the
levels of Casp3, Casp6 and Casp7 mRNA were unaffected by Wnt5a/
Wnt11 treatment. To determine if the synergistic effects of Wnt5a and
Wnt11 on Isl1 and Nkx2.5 expression were associated with increased
Caspase activity, lysates from treated and control EBs were subject to
Western blotting with antibodies recognizing cleaved-Casp3 as well as
the activated forms of Casp6 and Casp7 generated by initiator Caspase
cleavage at asparagine 162 and 198, respectively (Fig. 2B). Interestingly,
the levels of cleaved-Casp3, cleaved-Casp6 and cleaved-Casp7 were
moderately elevated in EBs treated with Wnt11 alone and stron-
gly elevated in EBs treated with Wnt5a and Wnt11 in combination.
Fig. 1. Wnt5a and Wnt11 are co-required for non-apoptotic Caspase activity in the SHF. (A) and (C) Longitudinal sections of E9.5 wild type and Wnt5a/; Wnt11 /
embryos were stained for cleaved-Casp3 (brown staining). Cleaved-Casp3 levels were higher in the walls of the outﬂow tract (OFT), dorsal mesocardium (DM, arrowheads)
and the roof of the OFT (dashed brackets) of wild type than of Wnt5a/; Wnt11/ embryos. (B) and (D) Cells in the OFT (arrows), DM (arrowheads) and the roof of the OFT
(dashed brackets) were not labeled by TUNEL staining in adjacent sections of wild type (B) or Wnt5a/; Wnt11/ (D) embryos. (E) and (F) In contrast, large numbers of
cells within the otic placodes (arrows) and neural tubes (arrowheads) stained strongly for both cleaved-Casp3 and TUNEL in frontal sections of E9.5 Wnt5a/; Wnt11 /
embryos.
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A commercially available luciferase-based reporter, CaspaseGlo 3/7
(Promega) was used to assess whether the elevated levels of cleaved-
Casp3 and cleaved-Casp7 observed by Western blotting corresponded
to an increase in activity (Fig. 2C). As expected, CaspaseGlo 3/7,
revealed that Casp3/7 activity was higher in Wnt5a/Wnt11 treated
EBs compared to untreated controls. Importantly, levels of the
unprocessed forms of Casp3, Casp6 and Casp7 were not increased
by Wnt5a/Wnt11 treatment, suggesting that the effects of these
ligands on Caspase activity are achieved through increased post-
translational processing.
Caspase activity is required for SHF progenitor cells and Wnt5a/
Wnt11 signaling
While Wnt11 was shown to promote the maturation of P19 cell
derived cardiomyocytes through the Caspase-dependent inhibition of
the canonical Wnt pathway (Abdul-Ghani et al., 2011), these experi-
ments focused on later events of cardiac differentiation, such as the
expression of contractile proteins and formation of sarcomeres, and
did not examine the effects of Wnt-induced Caspase activity on
cardiac progenitor cells. To address this issue, EBs were generated
from the TL1 strain of wild type mouse ES cells as well as ES cells that
were either heterozygous or homozygous for a null allele of Casp3
(Cohen et al., 2012; Fujita et al., 2008). Q-PCR revealed that Casp3
mRNA was lower in Casp3þ / EBs than in WT EBs and below
detection in Casp3 / EBs on day 5 of differentiation while the
expression of Casp6 and Casp7 were unaffected (Fig. 3A). The levels of
Isl1 and Nkx2.5 mRNAwere also moderately reduced in Casp3þ / EBs
and strongly reduced in the Casp3 / EBs relative to wild type control
EBs at this time, indicating that Casp3 is required for cardiac
progenitor development in vitro. To assess how the loss of Casp3
function affected SHF development over time, the levels of Isl1 mRNA
were examined in Casp3þ / and Casp3 / EBs between days 2 and
6 of differentiation (Fig. 3B). Although the levels of Isl1 mRNA
increased sharply between days 3 and 4 of differentiation in
Casp3þ / EBs, Isl1 expression was only slightly higher on day 4 of
differentiation than it was on day 3 in Casp3 / EBs. Furthermore,
while the levels of Isl1 mRNA declined between days 4 and 6 of
differentiation in Casp3þ / EBs, Isl1 levels increased in Casp3 / EBs
over this period and were nearly equivalent to those found in
Casp3þ / EBs by day 6 of differentiation. These data suggest that
Casp3 loss-of-function causes a delay rather than a loss of SHF
development and may explain why the Casp3 mutant mice from
which the Casp3þ / and Casp3 / ES cell lines were generated were
reported to be partially viable and have morphologically normal
hearts (Fujita et al., 2008; Kuida et al., 1996).
While the low levels of Isl1 and Nkx2.5 mRNA in Casp3/ EBs
relative to WT and Casp3þ / EBs suggest that Casp3 plays a role in
SHF development, it remains possible that these SHF markers are
reduced as a secondary consequence of the poor health of Casp3 /
EBs. We therefore sought to determine if Casp3 overexpression was
sufﬁcient to induce Isl1 and Nkx2.5. EBs were made from ES cells that
expressed either a constitutively active (rev-Casp3-CA) or an inactive
mutant (rev-Casp3-mut) form of Casp3 in response to doxycycline
(Fujita et al., 2008). On day 4 of differentiation, EBs were treated with
doxycycline for 24 h before having their levels of Isl1 and Nkx2.5
mRNA examined by Q-PCR (Fig. 3C). In the presence of doxycycline,
EBs made from rev-Casp3-CA cells expressed Isl1 and Nkx2.5 at higher
levels than in they do in control media, suggesting that Casp3
activation is sufﬁcient to promote cardiac progenitor development
during ES cell differentiation. In contrast, doxycycline treatment does
not affect Isl1 and Nkx2.5 expression in EBs made from rev-Casp3-mut
ES cells.
Although these data indicate that Casp3 is necessary and sufﬁcient
for SHF progenitor gene expression, the effects of Casp3 on Isl1 and
Nkx2.5 mRNA levels could still be distinct from those caused by
Wnt5a and Wnt11. However, if Caspases act in a pathway that
mediates Wnt5a/Wnt11 signaling, Caspase function will be required
for Wnt5a and Wnt11 to induce SHF gene expression. EBs were
therefore treated with recombinant Wnt5a and Wnt11 proteins as
described but with the addition of either Z-VAD-FMK or its vehicle
DMSO to the culture media at the time of Wnt treatment on day 4 of
differentiation. On day 6 of differentiation, mRNA was isolated from
EBs and examined for changes in Isl1 and Nkx2.5 expression (Fig. 3D
and E, respectively). Consistent with our previous data, Isl1 and
Nkx2.5 mRNA levels were increased by combined Wnt5a/Wnt11
treatment without the inhibitor. In contrast, Isl1 and Nkx2.5 were
reduced in EBs treated with Wnt5a and Wnt11 in the presence of
Z-VAD-FMK, suggesting that Caspase activity is required for Wnt5a
and Wnt11 to induce cardiac progenitor gene expression in differ-
entiating ES cells.
While the ability of z-VAD-FMK to inhibit multiple Caspases
circumvents problems caused by functional redundancy, it prevents
this inhibitor from being used to distinguish between roles played by
individual Caspase family members. Moreover, since z-VAD-FMK can
inhibit other families of cysteine proteases such as the Papains (Garcia-
Calvo et al., 1998; Slee et al., 1996), Calpains (Rozman-Pungercar et al.,
2003) and Cathepsins (Wolf et al., 1999), it is unclear if the effects of
Fig. 2. Wnt5a and Wnt11 signal cooperatively to activate Caspases in differ-
entiating ES cells. (A) Graph shows the results of Q-PCR for Isl1, Nkx2.5, Casp3,
Casp6 and Casp7 performed on RNA from EBs treated with 200 ng/ml Wnt5a,
200 ng/ml Wnt11 or 100 ng/ml Wnt5a and 100 ng/ml Wnt11 on day 4 of differ-
entiation and harvested after 48 h. (B) Western blots for both the cleaved and
uncleaved forms of Casp3, Casp6 and Casp7 as well as β-tubulin were performed on
lysates from EBs treated with Wnt5a, Wnt11 or Wnt5a and Wnt11 on day 4 of
differentiation as described and harvested after 24 h. (C) Graph shows the results of
CaspaseGlo-3/7 assays, a luciferase-based reporter of Casp3 and Casp7 activity,
performed on EBs treated with control media or media containing both 100 ng/ml
Wnt5a and 100 ng/ml Wnt11 on day 4 of differentiation and harvested 24 h later.
Graphs represent the mean of 3 independent replicates7the standard deviation.
Astericks (*) indicate Po0.05 vs. controls.
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this inhibitor on Wnt5a/Wnt11 signaling stem from a loss of Caspase
activity. To address this issue, wild type ES cells were transfected with
either an empty expression vector or an expression vector encoding
the cellular Inhibitor of apoptosis protein 2 (cIAP2), also known as
Baculoviral IAP repeat 3 (Birc3), which binds and ubiquitinates Casp3
and Casp7 to inhibit their activity (Schotte et al., 1999). Birc3
expressing and control EBs were generated from the transfected cells
and cultured in either control or Wnt5a/Wnt11 containing media
between days 4 and 6 of differentiation before being harvested for the
examination of gene expression. While Isl1 and Nkx2.5 levels were
higher in vector transfected EBs that had been treated with Wnt5a
andWnt11 than in those that were cultured in control media (Fig. 3F),
Wnt5a andWnt11 did not affect the expression of these genes in Birc3
expressing EBs suggesting that Casp3 and Casp7 are required for the
effects of Wnt5a and Wnt11 on SHF gene expression. To further
determine if Casp3 was uniquely required for Wnt5a/Wnt11 signaling,
Casp3þ / and Casp3/ EBs as well as WT EBs treated with either
DMSO or Ac-DEVD-CHO, a potent inhibitor and more speciﬁc inhibitor
of Casp3 (Huang et al., 2000; Verhagen et al., 2001), were cultured in
the presence or absence ofWnt5a andWnt11 between days 4 and 5 of
differentiation before being harvested for Q-PCR. In agreement with
our previous data, the levels of Isl1 mRNA were higher in Casp3þ /
and DMSO treated EBs that had been treated with Wnt5a and Wnt11
than in their untreated counterparts (Fig. 3G and E, respectively). In
contrast, Wnt5a and Wnt11 did not increase Isl1 expression in
Casp3 / or Ac-DEVD-CHO treated EBs, consistent with Casp3 being
uniquely required for the effects of Wnt5a and Wnt11 on cardiac
progenitor gene expression during ES cell differentiation.
Fig. 3. Caspase activity is necessary and sufﬁcient for the effects of Wnt5a and Wnt11 on cardiac progenitor cells in vitro. (A) Casp3þ /þ , Casp3þ / and Casp3/ EBs
were harvested on day 5 of differentiation and analyzed for Isl1, Nkx2.5, Casp3, Casp6 and Casp7 expression. Graph shows the fold change in the expression of each gene in
Casp3þ / and Casp3/ EBs relative that found in Casp3þ /þ EBs, which are normalized to one. Casp3 mRNA was below the levels of detection in Casp3/ EBs and
therefore marked as not detected (N.D.). (B) Casp3þ / and Casp3 / EBs were harvested once every 24 h between days 2 and 6 of differentiation and analyzed for Isl1
expression. The graph shows the levels of Isl1 in Casp3þ / and Casp3/ EBs on each day expressed as a fold change relative to those in Casp3þ / EBs on day 2 of
differentiation, which were normalized to one. (C) EBs made from rev-Casp3-CA and rev-Casp3-mut ES cells were treated with doxycycline between days 4 and 5 of
differentiation and then anazyzed for Isl1 and Nkx2.5 expression. Graphs show the fold changes in Isl1 and Nkx2.5 expression relative to the levels found in rev-Casp3-mut
EBs cultured in the absence of doxycycline. (D) and (E) EBs made fromwild type mouse ES cells were treated with Wnt5a, Wnt11 or both Wnt5a and Wnt11 as described but
with the addition of either 10 mM Z-VAD-FMK or DMSO to the culture media. Graph shows the fold changes in Isl1 (D) and Nkx2.5 (D) expression under each condition
relative to the levels in untreated EBs in DMSO containing media, which were normalized to one. (F) EBs made from ES cells transfected with empty and Birc3 expressing
vectors were cultured in control media and media with 100 ng/ml Wn5a and 100 ng/ml Wnt11 between days 4 and 5 of differentiation before being harvested and analyzed
for Isl1 and Nkx2.5 expression. Graph shows the levels of Isl1 and Nkx2.5 for each condition expressed as a fold change relative to the levels in empty vector transfected EBs
cultured in control media. (G) Casp3þ / and Casp3 / EBs were cultured in the presence or absence of Wnt5a and Wnt11 as described between days 4 and 5 of
differentiation before being harvested and analyzed for Isl1 expression. Graph shows the fold changes in Isl1 levels for each condition relative to those present in untreated
Casp3þ / EBs. (H) EBs made from TL1 ES cells were treated with Wnt5a and Wnt11 as described in media containing either 1 mM Ac-DEVD-CHO or its vehicle DMSO from
days 4–5 of differentiation before being harvested and analyzed for Isl1 expression. Graph shows the fold changes in Isl1 expression under each condition relative to that
found in untreated EBs cultured in DMSO containing media, which were normalized to one. All graphs show the mean results of 3 independent replicates7the standard
deviation. Asterisks (*) indicates Po0.05 vs. controls.
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Fig. 4. In utero pharmacological inhibition of Caspase activity reduces SHF gene expression in gestating embryos. (A)–(K) Pregnant dams were injected with Z-VAD-
FMK and DMSO as described in the Materials and methods section. (A)–(N) Embryos were harvested on E9.5 and processed for histological sectioning. (A)–(J) Longitudinal
sections through the OFT of DMSO (A–E) and Z-VAD-FMK treated embryos (F–J). (A) and (F) Staining for cleaved-Casp3 (brown) is reduced in the OFT walls (arrows), OFT roof
(small arrowheads) and endocardium (large arrowheads) of Z-VAD-FMK treated embryos (F) relative to those of DMSO treated controls (A). Counterstaining with
hematoxylin (blue in A and F) is unaffected. (B), (C), (G) and (H) Staining for Isl1 (red) is reduced in the posterior wall (arrows) and roof (small arrowheads) of the OFT in
Z-VAD-FMK treated embryos (G and H) relative to DMSO treated controls (B and C) while staining with DAPI (blue in C and H) is unaffected. Isl1 is not affected in the
endocardial cells (large arrowheads) of Z-VAD-FMK treated embryos relative to control. (D), (E), (F) and (J) Isl1 (red) is similarly reduced in the anterior wall of the OFT
(arrows) in Z-VAD-FMK treated embryos (I and J) relative to DMSO treated controls (D and E) but remains unaffected in endocardial cells (large arrowheads). DAPI staining
(blue in E and J) is unaffected by Z-VAD-FMK treatment. (K)–(N) Cross sections of Z-VAD-FMK (L and N) and DMSO (K and M) treated embryos stained for Isl1 (brown in K
and L) and Nkx2.5 (brown in M and N). Isl1 and Nkx2.5 are reduced in the both the DM (arrows) and foregut endoderm (arrowheads) in Z-VAD-FMK treated embryos relative
to controls. (O) and (P) Longitudinal sections of Z-VAD-FMK (P) and DMSO (O) treated embryos collected at E8.25–E8.5 (prior to turning) stained for Isl1 (red) and DAPI
(blue). The numbers of Isl1 positive SHF progenitors (arrows) entering the anterior pole (AP) of the heart tube (outlined by dashed lines) are decreased in Z-VAD-FMK treated
embryos relative to DMSO treated controls. Very few Isl1 positive cells are present in the posterior pole (PP) of the heart tube in either condition. (Q) Graph shows Isl1,
Nkx2.5 and Tnni3 mRNA levels in E9.5 Z-VAD-FMK treated embryos as fold changes relative to the levels of each gene in DMSO treated controls, which were normalized to
one. (R) Graph shows Isl1 and Nkx2.5 mRNA levels in the hearts of E9.5 embryos from Ac-DEVD-CHO injected females (described in the Materials and methods section) as
fold changes relative to the levels each gene present in controls. (S) Graph shows the levels of PlexinA2 and p75 mRNA in E9.5 Z-VAD-FMK treated embryos as fold changes
relative to DMSO treated controls. Graphs in (Q)–(S) represent the mean for 3 pools of RNA for each condition 7standard deviation. Asterisks (*) indicate Po0.01.
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Caspase activity is required for SHF development in vivo
A pharmacological approach was used to determine if inhibit-
ing the activities of multiple Caspases would disrupt SHF devel-
opment in vivo. Pregnant female mice were given daily intra-
peritoneal injections of either Z-VAD-FMK or DMSO between E6.5
and E8.5 of gestation before being sacriﬁced on E9.5 to study the
gestating embryos. Examination of H&E stained sections of Z-VAD-
FMK and DMSO treated embryos revealed that their overall
morphology was similar (data not shown). However, cleaved-
Casp3 staining was reduced in the OFT and DM (arrows in
Fig. 4A and B) as well as the roof of the OFT (small arrowheads
in Fig. 4A and B) and endothelial cells (large arrowheads in Fig. 4A
and B) of Z-VAD-FMK treated embryos relative to controls, con-
ﬁrming the efﬁcacy of Caspase inhibition. To determine if Isl1
positive SHF progenitor and CNC cells were affected by Caspase
inhibition, adjacent sections were ﬂuorescently co-stained with an
antibody recognizing Isl1 (red staining in Fig. 4B–E and G–J) and
DAPI, which labels cell nuclei (blue staining in Fig. 4B–E and G–J).
In DMSO treated embryos, strong Isl1 staining was present in the
nuclei of cells lining the both the DM and posterior wall of the OFT
(arrows in Fig. 4B and C) as well as the anterior wall of the OFT
(arrows in Fig. 4D and E). Furthermore, endothelial cells (large
arrowheads in Fig. 4B–E) as well as many of the cells within the
roof of the OFT (small arrowheads in Fig. 4B–D) also expressed Isl1.
In contrast to DMSO treated embryos, Isl1 staining was either
present at reduced levels or absent in the DM and posterior wall of
the OFT (arrows in Fig. 4G and H) as well as in the anterior wall of
the OFT (arrows in Fig. 4I and J) of Z-VAD-FMK treated embryos.
Isl1 expression in the roof of the OFT was also reduced or absent in
Z-VAD-FMK treated embryos (small arrowheads in Fig. 4G and H),
while Isl1 expression in endothelial cells was largely unaffected
(large arrowheads in Fig. 4G–J). Staining cross sections through
additional Z-VAD-FMK treated and control embryos for Isl1
(Fig. 4K and L) and Nkx2.5 (Fig. 4M and N) revealed reduced
staining for both markers in the DM (arrows in Fig. 4K–N) and
foregut endoderm (arrowheads in Fig. 4K–N). In agreement with
these ﬁndings, Q-PCR revealed that the levels of Isl1 and Nkx2.5
mRNA were lower in the hearts and adjacent mesenchyme of
Z-VAD-FMK treated embryos relative to controls (Fig. 4Q). In
contrast cardiac Troponin I (TnI), a marker of differentiated
cardiomyocytes, was expressed at similar levels in Z-VAD-FMK
treated and control embryos, suggesting that the more differen-
tiated descendants of FHF progenitors were unaffected by Caspase
inhibition. To conﬁrm that the loss of SHF markers caused by
Z-VAD-FMK injection reﬂects its inhibition of Caspases and not off
target effects on other cysteine proteases, pregnant female mice
were injected with either DMSO or the Casp3 inhibitor Ac-DEVD-
CHO before being sacriﬁced and having their embryos collected on
E9.5. Performing Q-PCR on the hearts and surrounding mesench-
yme of these embryos revealed that Isl1 and Nkx2.5 expression
was similarly reduced in the hearts of Ac-DEVD-CHO injected
embryos relative to controls (Fig. 4R). Taken together, these data
strongly suggest that Caspases play an essential role in SHF growth
and development in vivo.
The loss of Isl1 expression in the posterior walls and roof of the
OFT suggested that Caspase activity was also required for the
development of CNC cells. To address this possibility, the levels of
PlexinA2 and another marker of migratory neural crest cells, the
low-afﬁnity nerve growth factor receptor (p75) (Andrade-Rozental
et al., 1995; Rao and Anderson, 1997; Tropepe et al., 2009), were
examined in the hearts and surrounding mesenchyme of E9.5
DMSO and z-Vad-Fmk treated embryos by Q-PCR (Fig. 4S).
Interestingly, mRNA for both PlexinA2 and p75 were signiﬁcantly
reduced in the hearts of Z-VAD-FMK treated embryos relative
to controls, suggesting that Wnt5a and Wnt11 were
indeed required for CNC development. However, the effects of
combined Wnt5a/Wnt11 loss-of-function on SHF progenitor cells
are unlikely to be secondary to the loss of CNC since Isl1
expression is reduced in the hearts of z-Vad-Fmk treated embryos
relative to controls by E8.5, prior to the CNC cells entering the
heart (Fig. 4O and P).
Caspase activity is required for Wnt5a/Wnt11 signaling to inhibit the
canonical Wnt pathway
We previously showed that the loss of Isl1 positive SHF progenitor
cells in Wnt5a /; Wnt11/ embryos is associated with increased
canonical Wnt signaling in the OFT and surrounding mesenchyme
(Cohen et al., 2012). To determine if Caspase activity is similarly
required to prevent the inappropriate β-catenin signaling in the SHF,
longitudinal sections of E9.5 Z-VAD-FMK treated and control
embryos were stained with an antibody speciﬁc to the activated,
hypo-phosphorylated form of β-catenin. While low levels of acti-
vated β-catenin staining were observed in OFT walls of embryos from
DMSO injected mothers, levels of activated β-catenin were noticeably
increased in the OFT walls of embryos from Z-VAD-FMK injected
females (arrows in Fig. 5A). Moreover, Q-PCR indicated that the
canonical Wnt target gene Axin2 as well as two genes activated by
β-catenin in Isl1 positive progenitor cells, Bhlhb2 and Rora, were
expressed at higher levels in the hearts of Z-VAD-FMK treated
embryos than in those of controls (Fig. 5B). These results are
Fig. 5. Caspase activity is required for Wnt5a and Wnt11 to inhibit the canonical Wnt pathway. (A) Pregnant dams were injected with DMSO or Z-VAD-FMK as described
before being sacriﬁced at E9.5 and having their embryos harvested for histological sectioning. Longitudinal sections of DMSO (left) and Z-VAD-FMK (right) injected embryos
were stained for activated β-catenin. Staining was broader and more intense in the DM and OFT walls (arrows) as well as the roof of the OFT (arrowheads) of Z-VAD-FMK
treated embryos than in controls. (B) Graph shows the fold changes in Axin2, Bhlhb2 and Rora expression in the hearts of E9.5 Z-VAD-FMK injected embryos relative to the
levels of each gene in DMSO treated controls. (C)–(E) Graphs show the fold changes in Axin2 (C), Bhlhb2 (D) and Rora (E) mRNA in Casp3þ / and Casp3/ EBs collected
every 24 h from days 2–6 of differentiation as relative changes from the levels of each gene in Casp3þ / EBs on day 2. (F) EBs were treated with Wnt5a, Wnt11, or Wnt5a and
Wnt11 from days 4–5 of differentiation in the presence of DMSO or 10 mM Z-VAD-FMK. Western blotting reveals that β-catenin protein levels are reduced in EBs treated with
Wnt5a and Wnt11 in the presence of DMSO but not presence of Z-VAD-FMK. (G) EBs were cultured in either plain media or media containing 100 ng/ml Wnt5a and
100 ng/ml Wnt11 from days 4–5 of differentiation in the presence of either DMSO or 10 mM Z-VAD-FMK. Western blotting reveals that the levels of activated β-catenin are
reduced in EBs treated with Wnt5a and Wnt11 in the presence of DMSO but not in the presence of Z-VAD-FMK. (H) ES cells were co-transfected with the β-catenin reporter
SuperTopﬂash (STF) and a plasmid that constitutively expresses Renilla luciferase, which was used to control for transfection efﬁciency. EBs were generated from these cells
and treated with Wnt5a, Wnt11 or Wnt5a andWnt11 from days 4–5 of differentiation before being lysed and having their luciferase activity levels determined using the Dual
Luciferase Assay System (Promega). While STF activity was reduced in EBs treated with Wnt5a and Wnt11 in the presence of DMSO, Wnt5a and Wnt11 increased STF activity
relative to controls when EBs were treated in media containing 10 mM Z-VAD-FMK. (I) and (J) EBs were cultured in either plain media or media containing Wnt5a and Wnt11
from days 4–6 of differentiation in the presence of 10 mM Z-VAD-FMK (I), 1 mM Ac-DEVD-CHO (J) or DMSO before being harvested and analyzed for Bhlhb2 expression.
Bhlhb2 are lower in EBs treated with Wnt5a and Wnt11 in the presence of DMSO than in untreated EBs under equivalent conditions. In contrast, Bhlhb2 levels are increased
in EBs treated with Wnt5a and Wnt11 in the presence of either 10 mM Z-VAD-FMK or 1 mM Ac-DEVD-CHO relative to untreated EBs cultured in the presence of inhibitor.
(K) Graph shows the Bhlhb2 mRNA levels in Casp3þ / and Casp3/ EBs cultured in either plain media or media containing Wnt5a and Wnt11 from days 4–5 of
differentiation relative to those in untreated Casp3þ / EBs, which are normalized to one. (L) Graph shows Bhlhb2 mRNA levels in EBs made from ES cells transfected with
either empty vector or Birc3 expression plasmid cultured in either plain media or media containing Wnt5a and Wnt11 from days 4–5 of differentiation relative to those in
untreated EBs made from empty vector transfected cells, which are normalized to one. Graphs show the mean of 3 independent replicates7the standard deviation. Asterisks
(*) indicates Po0.05 vs. controls. The hashtags (#) in (H) and (I) indicate Po0.05 vs. untreated EBs in Z-VAD-FMK containing media. The hashtag (#) in (J) indicates Po0.05
vs. untreated EBs in Ac-DEVD-CHO containing media. The hashtag (#) in (K) indicates Po0.05 vs. untreated Casp3/ EBs.
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consistent with the reported increase in the activity of canonical Wnt
reporters observed in the myocardium of E12.5 embryos treated with
Caspase inhibitors in an ex vivo culture system (Abdul-Ghani
et al., 2011) and suggest that Caspase activity is required to suppress
excessive canonical Wnt signaling in the SHF during mouse embryo-
genesis.
To determine if the reduced expression of Isl1 and Nkx2.5 in
Casp3 / EBs was similarly associated with increased canonical
Wnt signaling, the levels of Axin2, Bhlhb2 and Rora mRNA in
Casp3 / and Casp3/þ EBs were analyzed by Q-PCR at several
times during their differentiation. Axin2 expression increased
between days 2 and 4 in both Casp3/ and Casp3 /þ EBs with
slightly higher levels of Axin2 mRNA in the Casp3 mutants
(Fig. 5C). However while Axin2 expression declined in Casp3þ /
EBs between days 4 and 6 of differentiation, Axin2 expression
continued to increase until day 5 in Casp3 / EBs and reached
levels nearly three-fold higher than those present in Casp3þ / EBs
before beginning to decline between days 5 and 6. Moreover,
while the levels of Bhlhb2 mRNA increased between days 2 and
3 of differentiation and then remained relatively constant through
day 6 in Casp3þ / EBs, Bhlhb2 expression increased dramatically
in Casp3 / EBs and reached levels over six-fold higher than those
found in Casp3 /þ EBs by day 5 before beginning to decline
between days 5 and 6 (Fig. 5D). Rora expression also increased
slowly throughout the differentiation of Casp3þ / EBs but rose
sharply between days 2 and 4 in Casp3 / EBs, reaching levels
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that were over seven-fold higher than those found in Casp3þ /
EBs on day 4 before declining (Fig. 5E). Taken together, these data
indicate that Casp3 inhibits β-catenin dependent transcription in
differentiating ES cells and suggest that the loss of Isl1 and Nkx2.5
in Casp3 / EBs results from increased canonical Wnt pathway
activation.
Our previous data indicated that canonical Wnt pathway
inhibition was both necessary and sufﬁcient for the effects of
cooperative Wnt5a/Wnt11 signaling on Isl1 and Nkx2.5 expression
in EBs (Cohen et al., 2012). The failure of Wnt5a and Wnt11 to
increase Isl1 and Nkx2.5 mRNA levels in the presence of Z-VAD-
FMK therefore suggests that Caspase activity may be required for
the effects of these ligands on the canonical Wnt pathway. To test
this hypothesis, EBs were treated with recombinant Wnt5a and
Wnt11 proteins in the presence or absence of Z-VAD-FMK as
described. EBs were then lysed and subjected to Western blotting
for total β-catenin (Fig. 5F) or the activated form of β-catenin
(Fig. 5G). Consistent with our previous ﬁndings, β-catenin levels
were reduced in EBs treated with both Wnt5a and Wnt11 in the
presence of DMSO relative to EBs treated with either Wnt on
its own or untreated control EBs. In contrast, Wnt5a/Wnt11
treatment did not reduce β-catenin levels in the presence of
Z-VAD-FMK, suggesting that the effects of cooperative Wnt5a/
Wnt11 signaling on the canonical Wnt pathway are Caspase-
dependent.
To more directly test whether Caspase activity is required for
cooperative Wnt5a/Wnt11 signaling to inhibit β-catenin dependent
transcription, ES cells were transiently transfected with super-
Topﬂash (STF), a reporter that uses tandem repeats of the consensus
TCF binding site to drive ﬁreﬂy luciferase expression in response to
canonical Wnt signaling (Veeman et al., 2003), as well as a plasmid
that constitutively expresses Renilla luciferase, which was used to
normalize for transfection efﬁciency. EBs were made from these STF
transfected ES cells and treated with Wnt5a and Wnt11 proteins in
the presence or absence of Z-VAD-FMK as described. After being
treated for 24 h, EBs were lysed and the levels of luciferase activity
determined. Consistent with our previous data, the STF activity was
reduced in EBs following combined Wnt5a/Wnt11 treatment in the
presence of DMSO relative to untreated controls (Fig. 5H). Surpris-
ingly, combined Wnt5a/Wnt11 treatment increased STF activity
relative to controls in the presence of Z-VAD-FMK without increasing
β-catenin protein. To determine if this change in the effects of Wnt5a
and Wnt11 on STF activity correlated with changes in the expression
of endogenous β-catenin target genes, the levels of Bhlhb2 mRNA
were examined by Q-PCR (Fig. 5I). Consistent with our previous data,
the levels of Bhlhb2 mRNA were signiﬁcantly reduced in EBs treated
with Wnt5a and Wnt11 in DMSO containing media relative to
untreated control EBs. Moreover, the levels of Bhlhb2 mRNA were
higher in EBs cultured in Z-VAD-FMK containing media than in DMSO
treated controls and increased by Wnt5a/Wnt11 treatment. Similar
increases in Bhlhb2 expression were observed in EBs treated with
Wnt5a and Wnt11 in the presence of Ac-DEVD-CHO (Fig. 5J) and
Wnt5a/Wnt11 treated Casp3/ EBs (Fig. 5K). While the mechanisms
behind this increase in β-catenin-dependent transcription remain
unclear, these data are consistent with the decreased Isl1 and Nkx2.5
expression observed in EBs treated with Wnt5a and Wnt11 in the
presence of Z-VAD-FMK. These data suggest that the changes in the
effects of Wnt5a/Wnt11 signaling on β-catenin dependent transcrip-
tion are speciﬁcally caused by the inhibition of Caspases and not the
result of off target effects on other cysteine proteases. Interestingly,
while Birc3 prevents the increase in Isl1 and decrease in Bhlhb2
expression caused by Wnt5a andWnt11 (Fig. 3F and 5L, respectively),
Wnt5a and Wnt11 do not increase Bhlhb2 expression in EBs made
from Birc3 transfected cells suggesting that Birc3 may inhibit Wnt5a/
Wnt11 signaling via mechanisms that extend beyond their inhibition
of Caspase function.
Wnt5a/Wnt11 signaling promotes SHF development via the Caspase-
dependent degradation of AKT
Wnt11 was shown to induce the maturation of P19 cell derived
cardiomyocytes by activating the Caspase-dependent cleavage of β-
catenin (Abdul-Ghani et al., 2011). However, we had previously found
that inhibiting Gsk3α⧸β blocked the ability of Wnt5a and Wnt11 to
inhibit the canonical Wnt pathway and promote cardiac progenitor
gene expression in differentiating ES cells (Cohen et al., 2012). Since
the direct proteolysis of β-catenin by Caspases would circumvent the
need for Gsk3α⧸β to target β-catenin to the proteasome for
degradation, these later data suggest that Wnt5a/Wnt11 induced
Caspase activity inhibits the canonical Wnt pathway by targeting
components that lie upstream of or in parallel to Gsk3α⧸β.
Phosphorylation by the serine/threonine kinase Akt has been
shown to inhibit Gsk3α⧸β activity and increase β-catenin signal-
ing in many cell types, including cardiac progenitor cells and
cardiomyocytes (Cross et al., 1995; Doble and Woodgett, 2003).
(Moreover, Caspases have been shown to cleave Akt and down-
regulate its activity (Riesterer et al., 2004; Rokudai et al., 2000;
Widmann et al., 1998). Taken together, these data raised the
question of whether Wnt5a/Wnt11 signaling promoted cardiac
progenitor development by reducing Akt activity. To investigate
this hypothesis, sections of Wnt5a /; Wnt11/ embryos were
stained with an antibody recognizing the phosphorylation of Akt
at serine 473 (p-Akt), which correlates with its activity (Jacinto
et al., 2006; Sarbassov et al., 2005). Examination of the stained
sections by light microscopy revealed that p-Akt levels were
higher in the OFT and adjacent mesenchyme of Wnt5a/;
Wnt11/ embryos (arrows in Fig. 6A and B). p-Akt staining was
similarly increased in the OFT and neighboring mesenchyme of
Z-VAD-FMK treated embryos relative to controls (arrows in Fig. 6C
and D). Taken together, these data suggest that Wnt5a and Wnt11
are co-required for the Caspase-mediated reduction of Akt signal-
ing during SHF development.
Caspases have previously been shown to proteolyze Akt (Jahani-
Asl et al., 2007; Widmann et al., 1998), suggesting that Wnt5a and
Wnt11 may reduce Akt activity by inducing its degradation. To
determine if Wnt5a and Wnt11 induced the Caspase-dependent loss
of Akt activity during ES cell differentiation, EBs were treated with
Wnt5a and Wnt11 between days 4 and 5 of differentiation in plain
media as well as media containing either DMSO or Z-VAD-FMK and
then analyzed for p-Akt levels. Interestingly, p-Akt levels were
speciﬁcally reduced in EBs treated with both Wnt5a and Wnt11 in
plain (Fig. 6E) and DMSO containing media (Fig. 6F) but not in media
containing Z-VAD-FMK. Moreover, Western blotting with a pan-Akt
antibody (Fig. 6E and F) as well as an antibody speciﬁc for Akt1
(Fig. 6F) revealed similar reductions in total Akt levels in EBs treated
with Wnt5a and Wnt11 in plain and DMSO containing media but not
in Z-VAD-FMK containing media. Since Akt1 mRNA was not affected
in Wnt5a/Wnt11 treated EBs (Fig. 6G), these data suggest that Wnt5a
and Wnt11 regulate Akt1 through a post-transcriptional mechanism
such as Caspase-mediated proteolysis. In contrast to Akt1, Akt2 was
only mildly reduced in EBs treated with either Wnt5a or Wnt11
relative to controls and not further decreased by combined Wnt5a/
Wnt11 treatment, suggesting that the effects of Wnt5a andWnt11 are
isoform speciﬁc
To determine if blocking Akt function would mimic the effects of
Wnt5a/Wnt11 signaling on cardiac progenitor cells, EBs were treated
with recombinant Wnt5a and Wnt11 proteins as described in addi-
tion to either Akt Inhibitor VIII (Akt-i-VIII), an isozyme-selective
inhibitor of AKT1 and 2 (Lindsley et al., 2005), PI-103, an inhibitor
of PI3K (Knight et al., 2006) or DMSO (Fig. 6H). As expected, levels of
Isl1 mRNA were signiﬁcantly higher in EBs treated with Wnt5a and
Wnt11 in DMSO containing media than in untreated EBs cultured in
DMSO. However, treatment with Akt-i-VIII or PI-103 in EBs without
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Wnt5a/Wnt11, elevated Isl1 expression to levels similar to those seen
with Wnt5a/Wnt11 treatment alone. Moreover, Wnt5a/Wnt11 plus
Akt-i-VIII or PI-103 treated EBs did not increase Isl1 expression
beyond that observed in EBs treated with the inhibitors alone. Taken
together, these data suggest that inhibiting Akt mimicks the effects of
Wnt5a/Wnt11 on the SHF.
To determine if blocking Akt was sufﬁcient to rescue the effects of
Casp3 loss-of-function on SHF development, Casp3þ / and Casp3 /
EBs were cultured in media containing either DMSO or Akt Inhibitor
VIII between days 4 and 5 of differentiation and then analyzed for Isl1
and Bhlhb2 expression. While the levels of Isl1 mRNA were lower
in Casp3/ EBs relative to Casp3/þ EBs in DMSO containing media,
treating Casp3 / EBs with Akt-i-VIII increased Isl1 expression
to levels equivalent to those present in Casp3þ / EBs (Fig. 6I).
Conversely, although Bhlhb2 expression was higher in Casp3/
EBs than in Casp3þ / when cultured in the presence of DMSO, the
levels of Bhlhb2 mRNA in Akt-i-VIII treated Casp3 / EBs was
equivalent to those found in Casp3þ / EBs. Together, these data
suggest that Akt inhibition is sufﬁcient to rescue the effects of Casp3
loss-of-function on both SHF development and the canonical Wnt
pathway.
The restoration of Isl1 and suppression of Bhlhb2 expression in
Akt-i-VIII treated Casp3/ EBs suggests that Caspases lie upstream of
Akt in the molecular pathway that mediates the effects of Wnt5a and
Fig. 6. Cooperative Wnt5a/Wnt11 signaling promotes SHF development by inducing the Caspase dependent loss of Akt protein. (A)–(D) Longitudinal sections of
Wnt5a/; Wnt11/ embryos (B) and wild type siblings (A) as well as embryos from Z-VAD-FMK (D) and DMSO (C) injected mothers were stained for Akt phosphorylated
at serine-473. Phospho-Akt (p-Akt) levels are higher in the OFT and DM of Wnt5a/; Wnt11 / and Z-VAD-FMK treated embryos than in controls (arrows). (E) Wild type
EBs were treated with Wnt5a, Wnt11 or both Wnt5a and Wnt11 from days 4–5 of differentiation and harvested to analyze the levels of p-Akt as well as the total levels of all
Akt isoforms (pan-Akt) by Western blotting. Both p-Akt and pan-Akt levels were speciﬁcally reduced in Wnt5a/Wnt11 treated EBs relative to controls. (F) EBs were treated
with Wnt5a, Wnt11 or both Wnt5a and Wnt11 from days 4–5 of differentiation and harvested. Western blotting revealed that the levels of p-AKT, pan-Akt and Akt1 were all
speciﬁcally reduced in EBs treated with both Wnt5a and Wnt11 in the presence of DMSO but not Z-VAD-FMK. (G) EBs were treated with Wnt5a, Wnt11 or Wnt5a and Wnt11
from days 4–5 of differentiation and harvested to analyze the levels of Akt1 mRNA by Q-PCR. Graph shows the levels of Akt1 expression for each condition expressed as fold
change from those in untreated controls, which were normalized to one. (H) EBs were treated with Wnt5a and Wnt11 from days 4–5 of differentiation in media containing
either DMSO, 1 mM Akt-i-VIII or 1mM PI-103. Graph shows the fold changes in Isl1 expression in EBs cultured under each condition relative to those in untreated EBs cultured
in DMSO containing media. (I) and (J) Graphs show the fold changes in the levels of Isl1 (I) and Bhlhb2 (J) mRNA in Casp3þ / and Casp3/ EBs treated with either DMSO or
1mM Akt-i-VIII from days 4–5 of differentiation relative to the levels in DMSO treated Casp3þ / EBs, which are normalized to one. (K) and (L) Graphs show the fold changes
in Isl1 (K) and Bhlhb2 (L) mRNA in EBs cultured from days 4–5 in media containing 100 nM XAV939 and 10 mM Z-VAD-FMK alone or in combination relative to the levels in
EBs cultured in DMSO containing media. (M), (N), and (L) Graphs show the fold changes in Isl1 (M), Bhlhb2 (N) and Axin2 (L) mRNA levels in EBs treated with either 50 nM
Bio or 50 nM meBio in media containing either 1 mM PI-103 or DMSO relative to those in untreated EBs cultured in the presence of DMSO. Graphs show the mean of
3 independent replicates 7 the standard deviation. Astericks (*) indicate Po0.01 vs. controls.
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Wnt11 on the SHF. To further conﬁrm the relationship between
β-catenin and Caspase activity in this pathway, wild type EBs were
cultured in either DMSO containing media or media containing the
Tankyrase inhibitor XAV939, which stabilizes Axin and blocks cano-
nical Wnt signaling (Huang et al., 2009), and Z-VAD-FMK, individually
as well as in combination, between days 4 and 5 of differentiation
before being analyzed for Isl1 and Bhlhb2 expression. Consistent with
our previous data, Isl1 mRNA levels were increased in XAV939 treated
EBs relative to DMSO treated EBs while Bhlhb2 expression was
reduced. Furthermore, while the levels of Isl1 and Bhlhb2 expression
were both mildly reduced in Z-VAD-FMK treated EBs relative to
controls, the increased Isl1 and decreased Bhlhb2 expression caused
by XAV939 treatment was unaffected by Z-VAD-FMK consistent with
Caspases acting upstream of β-catenin in the regulation of SHF
development.
To examine the relationship between PI3K/Akt signaling and
β-catenin signaling, wild type EBs were treated with either the
Gsk3α⧸β inhibitor Bio or (Meijer et al., 2003) or its inactive form
meBio in media containing either DMSO or PI-103 between days
4 and 5 of differentiation and analyzed for Isl1 and Bhlhb2 exp-
ression. Consistent with our previous data, the levels of Isl1 mRNA
in Bio treated EBs were reduced relative to those present in meBio
treated EBs and increased in PI-103 treated EBs relative to DMSO
treated EBs (Fig. 4M). Conversely, the levels of Bhlhb2 are higher in
Bio treated EBs than in meBio treated EBs and reduced in PI-103
treated EBs relative to EBs cultured in the presence of DMSO
(Fig. 4N). Consistent with Akt acting upstream of β-catenin in the
SHF, levels of Isl1 in EBs treated with Bio and PI-103 together are
not elevated but reduced to levels similar to those found in EBs
treated with Bio alone. Surprisingly however, the levels of Bhlhb2
in the EBs treated with Bio in the presence of PI-103 were
increased less than two fold relative to those found in EBs treated
with meBio and PI-103 and not signiﬁcantly increased relative to
the levels found in EBs treated with meBio in the presence of
DMSO. Similar results were observed for the expression of Axin2
(Fig. 6O). These data suggest inhibiting Gsk3α⧸β blocks the effects
of PI-103 on Isl1 expression without activating β-catenin depen-
dent transcription, although the mechanisms underlying this
effect remain to be determined.
Discussion
Wnt5a and Wnt11 are necessary and sufﬁcient for Caspase activity
in the SHF
We previously demonstrated that Wnt5a and Wnt11 signal
cooperatively to restrain canonical Wnt signaling in the SHF that
would otherwise disrupt cardiac progenitor development (Cohen
et al., 2012). However, while these data revealed an essential role
Wnt5a and Wnt11 in the SHF, the mechanisms underlying the
anti-canonical effects of these ligands were uncertain. A previous
study had shown that Wnt11 promoted later aspects of cardio-
myocyte differentiation, such as the expression of contractile
proteins and subsequent appearance of sarcomeres, through the
Caspase-dependent inhibition of β-catenin (Abdul-Ghani et al.,
2011). Consistent with these data, the levels of cleaved Casp3
observed in the hearts of Wnt5a /; Wnt11 / embryos were
lower than those found in wild type siblings, providing in vivo
genetic evidence for non-canonical Wnt ligands being required for
Caspase activity in the SHF. Moreover, treating EBs with Wnt5a
and Wnt11 caused a strong synergistic increase in the levels of
cleaved Caspases, mirroring the effects of these ligands on Isl1 and
Nkx2.5 expression. Together, these data suggest that the effects of
Wnt5a and Wnt11 on cardiac progenitor cells may be Caspase
mediated.
Recently, a lineage of cells that expresses both the CNC marker
Wnt1 and Isl1 at some time in its history has been identiﬁed (Engleka
et al., 2012). Since Wnt1 is only expressed in CNC cells in the dorsal
neural tube and rapidly repressed after these cells delaminate and
migrate toward the heart (Danielian et al., 1997), these results suggest
that a subset of CNC cells express Isl1 in addition to SHF progenitor
cells. Sections of Wnt5a /; Wnt11 / and wild type embryos were
therefore co-stained for Isl1 and the CNC marker PlexinA2 to
determine if these Isl1 expressing CNC cells are affected by Wnt5a/
Wnt11 loss of function. Surprisingly, the majority of Isl1 positive cells
in the posterior wall of the OFT and adjacent DM co-stained for both
markers, suggesting that these cells were in fact Isl1 expressing CNC
and not SHF progenitor cells. Moreover, the expression of both Isl1
and PlexinA2 were reduced or absent throughout the hearts of
Wnt5a/; Wnt11 / embryos, suggesting that these ligands are
co-required for both SHF progenitors and CNC cells, including those
that express Isl1. However, the effects of Wnt5a/Wnt11 and Caspase
loss-of-function on SHF progenitors are unlikely to be secondary
effects caused by the loss of CNC cells since the numbers of Isl1
positive cells were reduced in both Wnt5a /; Wnt11/ (Cohen
et al., 2012) and Z-VAD-FMK treated embryos by E8.5, prior to the
arrival of CNC cells to the heart. Moreover, it remains possible that
some SHF progenitor cells may express PlexinA2 and it will be
necessary to conﬁrm these results by analyzing the effects of
Wnt5a/Wnt11 and Caspase loss-of-function on Wnt1cre fate mapping.
Caspase activity is necessary and sufﬁcient for the effects of Wnt5a
and Wnt11 on SHF progenitors
Although SHF progenitors have yet to be examined in Caspase
mutant mice, heart phenotypes had been observed in Casp8 mutant
and Casp3/Casp7 double mutants (Lakhani et al., 2006; Varfolomeev
et al., 1998). However, subsequent studies showed that the heart
phenotypes of Casp8 / mice could be partially rescued by culturing
embryos ex vivo and mimicked by conditionally deleting Casp8 in
endothelial cells (Kang et al., 2004; Sakamaki et al., 2002), suggesting
that these defects resulted from the disruption of the yolk-sac
vasculature. Moreover, the heart defects found in Casp3 /;
Casp7 / mice are relatively mild and likely to result from later
defects in myocardial maturation (Lakhani et al., 2006), suggesting
that effects on the SHF may have been masked by the extensive
overlap between the functions of Caspase-family members. To
circumvent these issues, an in utero pharmacological approach was
used to determine if Caspase function was required for SHF develop-
ment. Using this approach, we found that Isl1 and Nkx2.5 were
reduced as a result of Caspase inhibition. Since Isl1 and Nkx2.5 are
both essential for the growth and differentiation of SHF progenitor
cells (Cai et al., 2003; Prall et al., 2007), the above ﬁndings indicate
that Caspase activity is indeed required for SHF development in vivo.
Isl1 and Nkx2.5 are also reduced in Casp3 / EBs and increased by
the expression of a constitutively active form of Casp3. Moreover,
Wnt5a and Wnt11 treatment does not increase the expression of
cardiac progenitor markers or decrease the expression of β-catenin
target genes in either Casp3 / or Caspase inhibitor treated EBs
relative to controls, suggesting that Caspase activation is necessary
and sufﬁcient for the effects of cooperative Wnt5a/Wnt11 signaling
on the SHF. Interestingly, Wnt5a and Wnt11 increased the levels of
STF activity in Casp3 / and Caspase inhibitor treated EBs. While it is
unclear why blocking Caspase function reversed the effects of Wnt5a
and Wnt11 on β-catenin-dependent transcription, Wnt5a and Wnt11
were shown to synergistically activate canonical Wnt signaling during
in early Xenopus embryos (Cha et al., 2008, 2009). These data raise
the possibility that Caspases may function as a molecular switch
that determines whether Wnt5a and Wnt11 promote or antagonize
Wnt/β-catenin signaling.
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Wnt5a and Wnt11 may promote SHF development via the
Caspase-dependent loss of Akt protein
While the inhibition of canonical Wnt signaling by Wnt11 in
P19 cells has been attributed to the direct cleavage of β-catenin by
Caspases (Abdul-Ghani et al., 2011), we found that inhibiting
Gsk3α/β blocked the effect of Wnt5a and Wnt11 on both cardiac
gene expression and canonical Wnt signaling in EBs (Cohen et al.,
2012). Since inactivating Gsk3α⧸β would not affect canonical Wnt
signaling if β-catenin was being degraded, these data suggested
that Wnt5a and Wnt11 impinge on the canonical Wnt pathway
upstream or in parallel to the β-catenin degradation complex (see
Fig. 7). (Caspases have been shown to cleave a number of signaling
proteins, including the serine/threonine kinase Akt (Riesterer
et al., 2004; Rokudai et al., 2000; Widmann et al., 1998). It is well
established that Akt phosphorylates serine-21 and serine-9 of
Gsk3α and Gsk3β, respectively, to inhibit their activities (Cross
et al., 1995; Doble and Woodgett, 2003). Though the phosphoryla-
tion of Gsk3α⧸β by Akt does not affect β-catenin dependent
transcription in all cell types (Doble and Woodgett, 2003; Patel
et al., 2004; Wu and Pan, 2010; Yuan et al., 1999), activating Akt
signaling has been shown to promote canonical Wnt signaling
during the cardiac differentiation of both P19 and ES cells (Lian
et al., 2013; Naito et al., 2005). Surprisingly, we found that staining
for the phosphorylation of Akt at serine-473 was increased in both
Wnt5a /; Wnt11/ and Caspase inhibitor treated embryos rela-
tive to controls. Conversely, the levels of phosphorylated and total
Akt protein were reduced in EBs treated with Wnt5a and Wnt11
proteins in media containing DMSO but not a Caspase inhibitor,
suggesting that these ligands induce Caspase-dependent Akt degra-
dation. Furthermore, treating EBs with inhibitors of Akt or its
upstream activator PI3K increased Isl1 expression to levels compar-
able to those found in Wnt5a/Wnt11 treated EBs. Inhibiting Akt also
restored Isl1 and reduced Bhlhb2 expression in EBs made from
Casp3/ ES cells. Together, these data suggest that Wnt5a and
Wnt11 promote SHF progenitor growth and differentiation through
the Caspase-dependent loss of Akt.
Intriguingly, while treating EBs with the Gsk3α⧸β inhibitor Bio
blocked the increase in Isl1 expression caused PI-103, blocking
PI3K/Akt signaling also blocks the increased expression of β-catenin
target genes caused by Gsk3α⧸β inhibition. The ability of PI-103 to
block canonical Wnt signaling in the presence of Bio may reﬂect
the direct phosphorylation of β-catenin by Akt on Ser552, which
has been shown to promote β-catenin dependent transcription
(Fang et al., 2007). In contrast however, the ability of Bio to block
the increase in Isl1 expression caused by PI-103 without increasing
the transcription of β-catenin target genes is unexpected and
suggest that Gsk3α⧸β may promote SHF development through an
Fig. 7. Proposed model for how Wnt5a/Wnt11 signaling may reduce canonical Wnt signaling in the SHF by activating the Caspase-dependent degradation of Akt.
Binding of canonical Wnt proteins such as Wnt3a to a complex consisting of Frizzled and LRP5/6 activates DVL, which recruits Axin and Gsk3α⧸β to the plasma membrane to
prevent the phosphorylation of β-catenin. Binding of growth factors to tyrosine kinase receptors enhances canonical Wnt signaling by activating PI3K and Akt, which
phosphorylates Gsk3α⧸β and inhibits its activity. Wnt5a and Wnt11 induce Caspase-dependent Akt degradation, which disrupts the effects of PI3K/Akt signaling
on β-catenin-dependent transcription. A detailed explanation of the proposed pathway is provided in the discussion section. Factors that promote canonical Wnt signaling
are shown in red while factors that inhibit Wnt/β-catenin signaling are shown in blue.
J.A. Bisson et al. / Developmental Biology 398 (2015) 80–96 93
additional as of yet unidentiﬁed mechanism. Interestingly, Gsk3α⧸β
has been shown to phosphorylate the intracellular domain of Notch2
and attenuate the transactivation of its target genes (Espinosa et al.,
2003). Since Notch has been shown to inhibit cardiogenesis in
differentiating stem cells (Jang et al., 2008; Li et al., 2012), Gsk3α⧸β
may play dual roles in restraining both canonical Wnt and Notch
signaling in the SHF that would otherwise disrupt cardiac progenitor
development, although this hypothesis remains to be tested.
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